Merck KGaA: raises full-year forecasts
(CercleFinance.com) - Germany's Merck has raised its full-year 2019 earnings forecast, following the closing of the Versum acquisition in October.
The drugs and chemicals group said it now expects "Ebitda pre," to be between 4.23 billion and 4.43 billion euros, compared to a previous guidance range of 4.15 billion and 4.35 billion euros.
The move comes as "Ebitda pre", the group's most important earnings indicator, increased even more strongly than net sales in three months from July to September.
It increased by 15.4% to 1.11 billion euros in the past quarter, while net sales rose by 8.1% to 4.05 billion euros.
The share is currently down 0.3% in Frankfurt after this report.
Copyright (c) 2019 CercleFinance.com. All rights reserved.